Paweł Buszman

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

Gregg W. Stone, Joseph F. Sabik, Patrick W. Serruys et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

Gregg W. Stone, A. Pieter Kappetein, Joseph F. Sabik et al. · New England Journal of Medicine · 2019 · 754 citations · Full text

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

Patrick W. Serruys, Sigmund Silber, Scot Garg et al. · New England Journal of Medicine · 2010 · 656 citations · Full text

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Stephan Windecker, Patrick W. Serruys, Simon Wandel et al. · The Lancet · 2008 · 650 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +10